DUBLIN, May 22, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval for the Android™ version of ...

The US Food and Drug Administration has approved a new stand-alone continuous glucose monitoring (CGM) system, Medtronic's Guardian Connect, that alerts users to impending high and low blood glucose ...

Medtronic plc. MDT recently made a major development in the field of diabetes management. The company reached an outcome-based agreement with Blue Cross and Blue Shield of Minnesota in relation to the ...

Medtronic has finally received FDA clearance for Guardian Connect, its smartphone-connected standalone CGM for patients who use multiple daily injections (MDI) for their insulin. Medtronic's ...

Medtronic plc has reported the launch of the Inpen integrated with real-time Guardian Connect continuous glucose monitoring (CGM) data. Inpen is the first U.S. FDA-cleared smart insulin pen on the ...